Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and Reteplase, recombinant Intravenous
Determining the interaction of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and Reteplase, recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
Generic Name: reteplase
Brand name: Retavase, Retavase Half-Kit
Synonyms: Reteplase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Retin A
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Retin-A (Tretinoin Cream)
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Retin-A (Tretinoin Gel)
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Retin-A Cream, Gel, Liquid
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Retin-A Micro
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Retin-A Micro Topical
- Reteplase, recombinant Intravenous-Omeclamox-Pak
- Reteplase, recombinant Intravenous-Omega-3 Fatty Acid Capsules
- Reteplase, recombinant Intravenous-Omega-3 Fatty Acids
- Reteplase, recombinant Intravenous-Omega-3 polyunsaturated fatty acids
- Reteplase, recombinant Intravenous-Omega-3-acid ethyl esters
- Reteplase, recombinant Intravenous-Omega-3-carboxylic acids